Evaluation of hydrogen peroxide virucidal efficacy against yellowfever virus 17DD vaccine strain for application in a vaccinemanufacturing industry
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
Texto Completo: | https://www.arca.fiocruz.br/handle/icict/53621 |
Resumo: | Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Departamento de Controle da Qualidade. Rio de Janeiro, RJ, Brasil. |
id |
CRUZ_a611c4148422d9265c6c083531b08c16 |
---|---|
oai_identifier_str |
oai:www.arca.fiocruz.br:icict/53621 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Ajório, Ana Carolina Ferreira BallestêRhodes, Vinícius PessanhaRodrigues, Anderson PeclatMoreira, Filipe MercêsDiniz, Vanessa AlvaroMattoso, Josiane Machado VieiraSilva, Igor Barbosa daGuedes Junior, Daniel da SilvaBrandão, Marcelo Luiz Lima2022-07-04T12:06:03Z2022-07-04T12:06:03Z2021AJORIO, A. C. F. B. et al. Evaluation of hydrogen peroxide virucidal efficacy against yellow fever virus 17DD vaccine strain for application in a vaccine manufacturing industry. Journal of Pharmaceutical and Biomedical Analysis, v. 204, n. 114264, p. 1-6, 2021.0731-7085https://www.arca.fiocruz.br/handle/icict/5362110.1016/j.jpba.2021.114264engPeróxido de HidrogênioValidação de limpezaVacinaVírus da Febre AmarelaDesinfecçãoInativação de VírusHydrogen peroxideCleaning validationVaccineYellow fever virusDisinfectionVirus inactivationPeróxido de HidrogênioVírus da Febre AmarelaDesinfecçãoInativação de VírusEvaluation of hydrogen peroxide virucidal efficacy against yellowfever virus 17DD vaccine strain for application in a vaccinemanufacturing industryinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleFundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Departamento de Controle da Qualidade. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Departamento de Controle da Qualidade. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Departamento de Controle da Qualidade. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Departamento de Controle da Qualidade. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Departamento de Controle da Qualidade. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Departamento de Controle da Qualidade. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Departamento de Controle da Qualidade. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Departamento de Controle da Qualidade. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Departamento de Controle da Qualidade. Rio de Janeiro, RJ, Brasil.The aim of this study was to evaluate the inactivation performance of hydrogen peroxide to the yellow fever virus 17DD vaccine strain, used for the production of attenuated yellow fever vaccine, in two matrixes: formulated yellow fever vaccine (FYV) and yellow fever viral suspension - active pharmaceutical ingredient (API). The samples were dried on stainless steel and exposed to hydrogen peroxide liquid (HPL) at concentrations of 30, 10, 3 and 1% for 20 and 60 min; and to hydrogen peroxide vapour (HPV) in an isolator. The exposure to HPL 30 and 10 %, within 20 min, reduced the virus titre at least 3.85 log10 PFU/mL (74.8 %). During 60 min of exposure, the HPL 30, 10 and 3% reduced the virus titre by at least 3.18 log10 PFU/mL (62.6 %). HPV exposure resulted in complete virus inactivation in FYV (≥ 4.42 log10 PFU/mL reduction) and for API samples 3.17 log10 PFU/mL (64.3 %) reduction. Hydrogen peroxide showed to be a promising disinfectant for elimination of yellow fever virus. However, the optimum concentration and contact time will vary depending on the type of application, and as such may complement individual risk assessments of biological production processes.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-83105https://www.arca.fiocruz.br/bitstream/icict/53621/1/license.txt612d7ba06cfe248f84ebe951752a8a5aMD51ORIGINALAjorio et al 2021.pdfAjorio et al 2021.pdfapplication/pdf684072https://www.arca.fiocruz.br/bitstream/icict/53621/2/Ajorio%20et%20al%202021.pdf1d6efbe778cdc6223a7c2a98bfb44f1cMD52icict/536212022-07-12 13:36:26.389oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352022-07-12T16:36:26Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.pt_BR.fl_str_mv |
Evaluation of hydrogen peroxide virucidal efficacy against yellowfever virus 17DD vaccine strain for application in a vaccinemanufacturing industry |
title |
Evaluation of hydrogen peroxide virucidal efficacy against yellowfever virus 17DD vaccine strain for application in a vaccinemanufacturing industry |
spellingShingle |
Evaluation of hydrogen peroxide virucidal efficacy against yellowfever virus 17DD vaccine strain for application in a vaccinemanufacturing industry Ajório, Ana Carolina Ferreira Ballestê Peróxido de Hidrogênio Validação de limpeza Vacina Vírus da Febre Amarela Desinfecção Inativação de Vírus Hydrogen peroxide Cleaning validation Vaccine Yellow fever virus Disinfection Virus inactivation Peróxido de Hidrogênio Vírus da Febre Amarela Desinfecção Inativação de Vírus |
title_short |
Evaluation of hydrogen peroxide virucidal efficacy against yellowfever virus 17DD vaccine strain for application in a vaccinemanufacturing industry |
title_full |
Evaluation of hydrogen peroxide virucidal efficacy against yellowfever virus 17DD vaccine strain for application in a vaccinemanufacturing industry |
title_fullStr |
Evaluation of hydrogen peroxide virucidal efficacy against yellowfever virus 17DD vaccine strain for application in a vaccinemanufacturing industry |
title_full_unstemmed |
Evaluation of hydrogen peroxide virucidal efficacy against yellowfever virus 17DD vaccine strain for application in a vaccinemanufacturing industry |
title_sort |
Evaluation of hydrogen peroxide virucidal efficacy against yellowfever virus 17DD vaccine strain for application in a vaccinemanufacturing industry |
author |
Ajório, Ana Carolina Ferreira Ballestê |
author_facet |
Ajório, Ana Carolina Ferreira Ballestê Rhodes, Vinícius Pessanha Rodrigues, Anderson Peclat Moreira, Filipe Mercês Diniz, Vanessa Alvaro Mattoso, Josiane Machado Vieira Silva, Igor Barbosa da Guedes Junior, Daniel da Silva Brandão, Marcelo Luiz Lima |
author_role |
author |
author2 |
Rhodes, Vinícius Pessanha Rodrigues, Anderson Peclat Moreira, Filipe Mercês Diniz, Vanessa Alvaro Mattoso, Josiane Machado Vieira Silva, Igor Barbosa da Guedes Junior, Daniel da Silva Brandão, Marcelo Luiz Lima |
author2_role |
author author author author author author author author |
dc.contributor.author.fl_str_mv |
Ajório, Ana Carolina Ferreira Ballestê Rhodes, Vinícius Pessanha Rodrigues, Anderson Peclat Moreira, Filipe Mercês Diniz, Vanessa Alvaro Mattoso, Josiane Machado Vieira Silva, Igor Barbosa da Guedes Junior, Daniel da Silva Brandão, Marcelo Luiz Lima |
dc.subject.other.pt_BR.fl_str_mv |
Peróxido de Hidrogênio Validação de limpeza Vacina Vírus da Febre Amarela Desinfecção Inativação de Vírus |
topic |
Peróxido de Hidrogênio Validação de limpeza Vacina Vírus da Febre Amarela Desinfecção Inativação de Vírus Hydrogen peroxide Cleaning validation Vaccine Yellow fever virus Disinfection Virus inactivation Peróxido de Hidrogênio Vírus da Febre Amarela Desinfecção Inativação de Vírus |
dc.subject.en.pt_BR.fl_str_mv |
Hydrogen peroxide Cleaning validation Vaccine Yellow fever virus Disinfection Virus inactivation |
dc.subject.decs.pt_BR.fl_str_mv |
Peróxido de Hidrogênio Vírus da Febre Amarela Desinfecção Inativação de Vírus |
description |
Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Departamento de Controle da Qualidade. Rio de Janeiro, RJ, Brasil. |
publishDate |
2021 |
dc.date.issued.fl_str_mv |
2021 |
dc.date.accessioned.fl_str_mv |
2022-07-04T12:06:03Z |
dc.date.available.fl_str_mv |
2022-07-04T12:06:03Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
AJORIO, A. C. F. B. et al. Evaluation of hydrogen peroxide virucidal efficacy against yellow fever virus 17DD vaccine strain for application in a vaccine manufacturing industry. Journal of Pharmaceutical and Biomedical Analysis, v. 204, n. 114264, p. 1-6, 2021. |
dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/53621 |
dc.identifier.issn.pt_BR.fl_str_mv |
0731-7085 |
dc.identifier.doi.pt_BR.fl_str_mv |
10.1016/j.jpba.2021.114264 |
identifier_str_mv |
AJORIO, A. C. F. B. et al. Evaluation of hydrogen peroxide virucidal efficacy against yellow fever virus 17DD vaccine strain for application in a vaccine manufacturing industry. Journal of Pharmaceutical and Biomedical Analysis, v. 204, n. 114264, p. 1-6, 2021. 0731-7085 10.1016/j.jpba.2021.114264 |
url |
https://www.arca.fiocruz.br/handle/icict/53621 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/53621/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/53621/2/Ajorio%20et%20al%202021.pdf |
bitstream.checksum.fl_str_mv |
612d7ba06cfe248f84ebe951752a8a5a 1d6efbe778cdc6223a7c2a98bfb44f1c |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1813008883477643264 |